SCHAUMBURG, Ill., Oct. 13, 2014 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America ® (CTCA) will feature multiple presenters at the 11th annual International Conference of The Society for Integrative Oncology taking place on October 26-28 in Houston, Texas. CTCA physicians will be making both oral and poster presentations in addition to the Plenary Session that will feature Maurie Markman, MD, President of Medicine and Science and a pre-conference workshop where Carolyn Lammersfeld, MS, RD, CSO, LD, CNSC, CTCA Vice President of Integrative Medicine will present.
The Society for Integrative Oncology has a mission to advance evidence-based, comprehensive, integrative healthcare to improve the lives of people affected by cancer. The three day conference is an opportunity for clinicians, researchers, patients and advocates to hear about and discuss the latest evidence-based integrative oncology.
"The conference is a great opportunity for CTCA to share the important role that integrative therapies play in the cancer journey," said Lammersfeld. "We are fortunate to have so many opportunities to present to this great field of accomplished professionals. Having attended the conference for years now, I know just how important this information is and how valuable the data sharing can be with regard to impacting patient care."
Dr. Markman's plenary session will be on the topic of Personalized Integrative Oncology. The plenary session will discuss personalized cancer therapies and how integrative oncology plays a role in the evolving world of personalized treatment. Lammersfeld will present at a pre-conference workshop on clinical and business models to provide integrative oncology care. Lammersfeld will specifically discuss the CTCA clinical care model and what is covered under insurance. Additionally she will share how integrative oncology can impact current and future sources of revenue.
Additional CTCA oral presentations include Kristen Trukova, MS, RD, and Digant Gupta, MD, MPH, discussing their paper entitled "Analysis of weight change in women with breast cancer through first year after chemotherapy." Irshad Ali, PhD, A. Rosales, and Donald Braun, PhD will deliver a presentation titled "Regulation of Wnt pathway components may be linked to augmented suppression of colorectal cancer cell proliferation by combination treatment of Resveratol and Mitomycin C." Additionally, Laura Sunn, MD, will present on the "Reduction of anxiety in patients undergoing radiologic exam."
CTCA clinical teams have also had four poster presentations accepted for presentation. Christina Shannon, ND will present a "Literature review on the association between Omega-3 fatty acids and prostate cancer." Katherine Puckett, PhD, and Stephanie Mazzanti, LCPC, will present on "The value of responding to staff wishes for care: comprehensive mind-body support services available to all stave at a cancer treatment hospital." Shauna Birdsall, ND, and Timothy Birdsall, ND, will present "Dietary supplements used concurrently with Conventional Treatment-A methodology for prevention of interactions." Ali, Rosales and Dr. Braun will also present a poster titled "Differential modulation of canonical and non-canonical Wnt signaling components by Resveratrol in primary colorectal, renal and pancreatic cancers results in suppression of cell proliferation."
"We are delighted that so many presentations have been accepted and will be shared at this conference," said Dr. Markman. "It is a great opportunity to put the work and research of our physicians and clinicians in a forum where it can help others gain perspective on how to treat cancer patients with integrative care."
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America, Inc. (CTCA) is a national network of hospitals that specializes in the treatment of patients who are fighting complex or advanced-stage cancer. CTCA offers an integrative approach to cancer treatment that combines surgery, radiation, and chemotherapy with nutritional counseling, naturopathic medicine, mind-body therapy, and spiritual support to enhance quality of life and minimize side effects during treatment. The company serves patients from all fifty states at hospitals located in Atlanta, Chicago, Philadelphia, Phoenix, and Tulsa. Known for delivering the Mother Standard® of care and Patient Empowered Care®, CTCA provides patients with comprehensive information about their treatment options so they can participate in their treatment decisions. For more information about CTCA, go to www.cancercenter.com.
Photo - http://photos.prnewswire.com/prnh/20090612/CTCALOGO
SOURCE Cancer Treatment Centers of America
Share this article